trial

Theta Burst Stimulation for Schizophrenia

NCTId NCT03288779
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 6 (actual)
Sponsored by Duke University
Primary completion 2018-06-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
6 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2017-10-24
Primary completion
2018-06-30
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Theta Burst Stimulation

Sponsors

Duke UniversityLead Sponsor

Investigators

1
Gopalkumar Rakesh, MDPrincipal Investigator

Sites

1 total
Durham, United States

Facts & assertions

4 sourced
Enrollment
6
Phase
NA
Primary Completion Date
2018-06-30
Status
COMPLETED
relationships
The graph out of here
drug
Theta Burst Stimulation
drug
lead_sponsor
Duke University
company
indication
Schizophrenia
indication
Schizoaffective Disorder
indication
Schizophrenia
indication
investigator
Gopalkumar Rakesh, MD
person